Tyrphostin (AG1478) is a selective EGFR inhibitor that disrupts EGFR autophosphorylation and signaling in cancer, including GB [14,49,50], inhibiting cell migration and invasion [51,52]. This evidence concerns the gene EGFR and cancer.